Michel Komajda



National Academy of Medicine, Paris, FR

  • OrcidID


Dr Michel Komajda is a Cardiologist at the National Academy of Medicine in Paris, France. He is a past president of the European Society of Cardiology and the French Cardiac Society. He has been a member of the steering comittee, clinical endpoint committee or DSMB of many notable heart failure clinical trials, including SHIFT, CORONA, I PRESERVE, COMET, PARADIGM HF, CARMEN, EMPHESUS, RENAISSANCE, and PARAGON. He has also published over 250 articles in peer-reviewed journals. 

Dr Michel Komajda is a member of the editorial board for the Journal of Asian Pacific Society of Cardiology, published by Radcliffe Cardiology on behalf of the Asian Pacific Society of Cardiology.

Articles by Michel Komajda, Cardiologist

Implementation of Guidelines in Heart Failure: Problems and Potential Solutions

Michel Komajda,


Citation: Journal of Asian Pacific Society of Cardiology 2024;3:e19.

Quality of Physician Adherence to Guideline Recommendations for Life-saving Treatment in Heart Failure: an International Survey

Martin R Cowie, Michel Komajda,

Citation: Cardiac Failure Review 2017;3(2):130–3.